Fluencia

Female infertility is a growing challenge, particularly in Europe. Although procedures such as in vitro fertilization (IVF) are available, their success rates remain limited. More than 50% of failed attempts are linked to poor timing of egg retrieval or embryo transfer. Patients must often undergo multiple blood tests over several weeks, while hormonal treatments can lead to serious side effects, including ovarian hyperstimulation syndrome.

Beyond infertility, conditions such as premature ovarian insufficiency and menopause also require continuous monitoring of hormone levels to improve diagnosis, treatment, and quality of life.

Our solution is real-time monitoring of critical hormones, including estradiol, using a wearable sensor designed like a skin patch placed on the abdomen. The sensor measures hormone levels in the interstitial fluid—the fluid that surrounds cells in body tissue—to precisely determine the ovulation window (24–48 hours) and support timely IVF treatment.

Publications

Fluencia

Female infertility is a growing challenge, particularly in Europe. Although procedures such as in vitro fertilization (IVF) are available, their success rates remain limited. More than 50% of failed attempts are linked to poor timing of egg retrieval or embryo transfer. Patients must often undergo multiple blood tests over several weeks, while hormonal treatments can lead to serious side effects, including ovarian hyperstimulation syndrome.

Beyond infertility, conditions such as premature ovarian insufficiency and menopause also require continuous monitoring of hormone levels to improve diagnosis, treatment, and quality of life.

Our solution is real-time monitoring of critical hormones, including estradiol, using a wearable sensor designed like a skin patch placed on the abdomen. The sensor measures hormone levels in the interstitial fluid—the fluid that surrounds cells in body tissue—to precisely determine the ovulation window (24–48 hours) and support timely IVF treatment.

Publications